Obesity treatment in adolescents and adults in the era of personalized medicine

Author:

Sundbom Magnus12,Järvholm Kajsa34,Sjögren Lovisa56ORCID,Nowicka Paulina7,Lagerros Ylva Trolle89ORCID

Affiliation:

1. Department of Surgical Sciences Uppsala University Uppsala Sweden

2. Department of Surgery University Hospital Uppsala Sweden

3. Department of Psychology Lund University Lund Sweden

4. Childhood Obesity Unit Skåne University Hospital Malmö Sweden

5. Department of Pediatrics Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg Gothenburg Sweden

6. Department of Pediatrics Region Västra Götaland, Sahlgrenska University Hospital Gothenburg Sweden

7. Department of Food Studies Nutrition and Dietetics Uppsala University Uppsala Sweden

8. Department of Medicine (Solna) Clinical Epidemiology Division Karolinska Institutet Stockholm Sweden

9. Center for Obesity, Academic Specialist Center Stockholm Health Services Stockholm Sweden

Abstract

AbstractIn this multi‐professional review, we will provide the in‐depth knowledge required to work in the expanding field of obesity treatment. The prevalence of obesity has doubled in adults and quadrupled in children over the last three decades. The most common treatment offered has been lifestyle treatment, which has a modest or little long‐term effect. Recently, several new treatment options—leading to improved weight loss—have become available. However, long‐term care is not only about weight loss but also aims to improve health and wellbeing overall. In the era of personalized medicine, we have an obligation to tailor the treatment in close dialogue with our patients. The main focus of this review is new pharmacological treatments and modern metabolic surgery, with practical guidance on what to consider when selecting and guiding the patients and what to include in the follow‐up care. Furthermore, we discuss common clinical challenges, such as patients with concurrent eating disorder or mental health problems, and treatment in the older adults. We also provide recommendations on how to deal with obesity in a non‐stigmatizing way to diminish weight stigma during treatment. Finally, we present six microcases—obesity treatment for persons with neuropsychiatric disorders and/or intellectual disability; obesity treatment in the nonresponsive patient who has “tried everything”; and hypoglycemia, abdominal pain, and weight regain after metabolic surgery—to highlight common problems in weight‐loss treatment and provide personalized treatment suggestions.

Publisher

Wiley

Reference88 articles.

1. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population‐representative studies with 222 million children, adolescents, and adults;NCD Risk Factor Collaboration (NCD‐RisC);Lancet.,2024

2. World Health Organization Obesity and overweight Fact sheet 1 March 2024.https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

3. Quality of life and obesity;Kolotkin RL;Obes Rev.,2001

4. Pediatric obesity‐long‐term consequences and effect of weight loss;Marcus C;J Intern Med.,2022

5. Early weight loss with liraglutide 3.0 mg predicts 1‐year weight loss and is associated with improvements in clinical markers;Fujioka K;Obesity (Silver Spring).,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3